Table 1 Clinical characteristics of the population according to type of treatment
From: Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
W and W | CT | Ri-CT | RT-CT | RT | Ri | |
|---|---|---|---|---|---|---|
Number | 36 | 26 | 36 | 19 | 21 | 7 |
Median age | 58 | 52.5 | 56 | 51 | 51 | 55 |
>65 years | 12 (33.3%) | 8 (30.8%) | 4 (11.1%) | 0 (0%) | 4 (19%) | 2 (28.6%) |
Gender | ||||||
M | 11 (30.6%) | 14 (53.8%) | 17 (47.2%) | 9 (47.4%) | 12 (57.1%) | 3 (42.9%) |
F | 25 (69.4%) | 12 (46.2%) | 19 (52.8%) | 10 (52.6%) | 9 (42.9%) | 4 (57.1%) |
Stage | ||||||
I | 22 (61.1%) | 9 (34.6%) | 14 (38.9%) | 17 (89.5%) | 19 (90.5%) | 3 (42.9%) |
II | 14 (38.9%) | 17 (65.4%) | 22 (61.1%) | 2 (10.5%) | 2 (9.5%) | 4 (57.1%) |
Bulky | ||||||
No | 36 (100%) | 17 (65.4%) | 20 (55.5%) | 18 (94.7%) | 21 (100%) | 5 (71.4%) |
Yes | 0 | 4 (15.4%) | 15 (41.7%) | 1 (5.3%) | 0 (0%) | 2 (28.6%) |
LDH | ||||||
N | N | 31 (86.1%) | 27 (75%) | 14 (73.7%) | 11 (52.4%) | 7 (100%) |
> N | > N | 1 (3.9%) | 6 (16.7%) | 2 (10.5%) | 0 (0%) | 0 (0%) |